These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38003288)

  • 21. Women's Health Hubs: a rapid mixed-methods evaluation.
    Daniel K; Bousfield J; Hocking L; Jackson L; Taylor B
    Health Soc Care Deliv Res; 2024 Sep; 12(30):1-138. PubMed ID: 39268794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Resilience Hub approach for addressing mental health of health and social care workers during the COVID-19 pandemic: a mixed-methods evaluation.
    Varese F; Allsopp K; Carter LA; Shields G; Hind D; Davies L; Barrett A; Bhutani G; McGuirk K; Huntley F; Jordan J; Rowlandson A; Sarsam M; Ten Cate H; Walker H; Watson R; Wilkinson J; Willbourn J; French P
    Health Soc Care Deliv Res; 2024 Sep; 12(29):1-164. PubMed ID: 39264827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis.
    Banerjee S; Kalyani Yabalooru SR; Karunagaran D
    Comput Biol Med; 2020 Dec; 127():104076. PubMed ID: 33126129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hub Protein Controversy: Taking a Closer Look at Plant Stress Response Hubs.
    Vandereyken K; Van Leene J; De Coninck B; Cammue BPA
    Front Plant Sci; 2018; 9():694. PubMed ID: 29922309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction and localization diversities of global and local hubs in human protein-protein interaction networks.
    Kiran M; Nagarajaram HA
    Mol Biosyst; 2016 Aug; 12(9):2875-82. PubMed ID: 27400769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stratus not altocumulus: a new view of the yeast protein interaction network.
    Batada NN; Reguly T; Breitkreutz A; Boucher L; Breitkreutz BJ; Hurst LD; Tyers M
    PLoS Biol; 2006 Oct; 4(10):e317. PubMed ID: 16984220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein interaction networks as metric spaces: a novel perspective on distribution of hubs.
    Fadhal E; Gamieldien J; Mwambene EC
    BMC Syst Biol; 2014 Jan; 8():6. PubMed ID: 24438364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connecting the αα-hubs: same fold, disordered ligands, new functions.
    Staby L; Bugge K; Falbe-Hansen RG; Salladini E; Skriver K; Kragelund BB
    Cell Commun Signal; 2021 Jan; 19(1):2. PubMed ID: 33407551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein evolution in yeast transcription factor subnetworks.
    Wang Y; Franzosa EA; Zhang XS; Xia Y
    Nucleic Acids Res; 2010 Oct; 38(18):5959-69. PubMed ID: 20466810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic hubs show competitive and static hubs non-competitive regulation of their interaction partners.
    Goel A; Wilkins MR
    PLoS One; 2012; 7(10):e48209. PubMed ID: 23118954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
    Kringelbach T; Højgaard M; Rohrberg K; Spanggaard I; Laursen BE; Ladekarl M; Haslund CA; Harsløf L; Belcaid L; Gehl J; Søndergaard L; Eefsen RL; Hansen KH; Kodahl AR; Jensen LH; Holt MI; Oellegaard TH; Yde CW; Ahlborn LB; Lassen U
    BMC Cancer; 2023 Feb; 23(1):182. PubMed ID: 36814246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
    Visintin M; Melchionna T; Cannistraci I; Cattaneo A
    J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the binding patterns of hub proteins: a study using yeast protein interaction networks.
    Andorf CM; Honavar V; Sen TZ
    PLoS One; 2013; 8(2):e56833. PubMed ID: 23431393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Domain distribution and intrinsic disorder in hubs in the human protein-protein interaction network.
    Patil A; Kinoshita K; Nakamura H
    Protein Sci; 2010 Aug; 19(8):1461-8. PubMed ID: 20509167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connectomic profile and clinical phenotype in newly diagnosed glioma patients.
    Derks J; Dirkson AR; de Witt Hamer PC; van Geest Q; Hulst HE; Barkhof F; Pouwels PJ; Geurts JJ; Reijneveld JC; Douw L
    Neuroimage Clin; 2017; 14():87-96. PubMed ID: 28154795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinctive Behaviors of Druggable Proteins in Cellular Networks.
    Mitsopoulos C; Schierz AC; Workman P; Al-Lazikani B
    PLoS Comput Biol; 2015 Dec; 11(12):e1004597. PubMed ID: 26699810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global connectivity of hub residues in Oncoprotein structures encodes genetic factors dictating personalized drug response to targeted Cancer therapy.
    Soundararajan V; Aravamudan M
    Sci Rep; 2014 Dec; 4():7294. PubMed ID: 25465236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On future's doorstep: RNA interference and the pharmacopeia of tomorrow.
    Gewirtz AM
    J Clin Invest; 2007 Dec; 117(12):3612-4. PubMed ID: 18060018
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.